AstraZeneca Stock And 2 UK Cash Flow Picks Trading Below Fair Value

With bond yields easing in several major markets, inflation trends diverging across regions, and oil prices swinging on geopolitical headlines, many investors are looking for opportunities grounded in actual cash being generated rather than just stories. That is where undervalued cash flow stocks come in. This article uses the Undervalued Stocks Based On Cash Flows screener, which focuses on companies that SWS DCF analysis suggests are trading below fair value, to help you focus on clear, numbers based cases. Ahead, you will see 3 stocks from this screener that stand out on cash flow and valuation metrics.

AstraZeneca (LSE:AZN)

Overview: AstraZeneca is a global biopharmaceutical company based in Cambridge that develops, manufactures, and sells prescription medicines across cancer, heart and kidney disease, respiratory and immune conditions, vaccines, and rare diseases. Its portfolio spans well known therapies such as Tagrisso, Imfinzi, Farxiga and Ultomiris, alongside newer treatments emerging from a large late stage pipeline.

Operations: AstraZeneca generates all of its approximately US$60.4b in revenue from pharmaceuticals.

Market Cap: £199.1b

AstraZeneca attracts attention because it combines a broad oncology focused pipeline, strong cash generation and a 21.9% ROE with an SWS DCF view that the stock trades below estimated fair value, alongside a rich P/E and high debt. Recent approvals and positive regulatory opinions for drugs such as Enhertu, Datroway and TRUQAP sit alongside setbacks like the Wainua trial. This highlights both the potential upside from successful launches and the risk when late stage assets miss endpoints. For investors, the key considerations include how this mix of high margin projects, patent and pricing pressures, insider selling and balance sheet leverage could all affect future cash flows and any potential repricing of AstraZeneca.

AstraZeneca’s combination of a rich P/E ratio, high debt and strong cash generation raises a sharper question: is the current share price properly weighing that trade-off or missing key pressure points in the DCF valuation analysis for AstraZeneca?

Foresight Group Holdings (LSE:FSG)

Overview: Foresight Group Holdings is a London based asset manager that runs infrastructure, private equity, venture capital and listed funds, with a strong tilt toward renewable energy, social infrastructure and other real assets for both institutions and retail investors. It sources, structures and manages investments across sectors and stages, from early venture to buyouts, aiming to provide access to long term, asset backed and sustainable cash flows.

Operations: Foresight Group Holdings generates about £114.8m from Real Assets and £50.1m from Private Equity, with most revenue coming from the United Kingdom and Australia.

Market Cap: £507.0m

Foresight Group Holdings is drawing interest because it sits at the intersection of energy transition themes and real asset demand, while also running a business that is already earning high margins and returns on equity. Some analysis, including Simply Wall St valuation work, highlights potential upside if assets under management expand and higher fee products continue to scale. However, investors still face questions about fee sensitivity, performance based income and heavy exposure to UK and European policy trends. Active share buybacks and ongoing earnings growth are additional factors in the story, but the key consideration is whether the current price reflects both the compounding potential and the operational and regulatory risks embedded in this model.

Foresight Group’s high margin, real asset focus and energy transition exposure suggest a bigger story than the current share price implies. See how the analyst forecasts for Foresight Group Holdings stacks up against its policy and fee risks.

BAE Systems (LSE:BA.)

Overview: BAE Systems is a global defense and aerospace company that supplies combat aircraft, ships, armored vehicles, munitions, electronic warfare systems, space hardware, and cyber security services to governments and defense customers worldwide.

Operations: BAE Systems generates most of its revenue from Electronic Systems (£7.5b), Air (£7.4b), Maritime (£6.6b) and Platforms & Services (£5.0b), with smaller contributions from Cyber & Intelligence (£2.4b) and Head Quarter activities, partially offset by intra group eliminations.

Market Cap: £52.5b

BAE Systems stands out on this cash flow focused screener because it combines a £75b order backlog and exposure to higher value areas like drones, munitions, electronic warfare and satellites with earnings growth that analysts expect to slightly outpace the wider UK market. At the same time, the stock carries trade offs investors need to weigh carefully, including a relatively high P/E, dependence on a handful of large US, UK and Saudi government programs, capacity constraints in areas such as missiles, and governance questions around board independence. If you are looking for a defense stock where cash flows, contracts and valuation are all in focus, BAE Systems may warrant closer consideration.

BAE Systems’ order backlog and higher value programs could be masking a much bigger story in its cash flows and valuation. Before assuming the market has priced it all in, review the analysis report for BAE Systems.

The three stocks in this article are only a starting point, as the full Undervalued Stocks Based On Cash Flows screener surfaced 36 more companies with cash flow stories and valuation gaps that may be just as compelling. Use Simply Wall St to identify, compare and analyze the specific catalysts, cash flow profiles and valuation narratives that matter most so you can focus on the highest conviction ideas in this group.

Take Control of Your Investment Journey

If BAE Systems or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives With Real Edge?

Fresh ideas often move first when momentum builds, and the most attractive entries can be gone before the crowd even looks. Scan these under the radar candidates while it matters and consider your options promptly.

• Target stable income streams by reviewing 3 dividend fortresses, a curated set of companies where higher yields are paired with balance sheets that analysts regard as relatively robust and currently flying under many radars.
• Explore potential infrastructure opportunities with 34 power grid technology and infrastructure stocks, featuring businesses tied to grid upgrades and electrification trends that may attract increased attention from investors over time.
• Monitor early AI infrastructure developments using 52 AI infrastructure stocks, a focused list of companies supplying the hardware and backbone that support data centers and high intensity computing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com